Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance.
Clinical Benefit
| Substantial |
The transparency Committee considers that the actual benefit of ARAVA continues to be substantial in the indications in the Marketing Authorisation. |
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
js28SLp5L4MT0EcX
Listen
